138 results
8-K
EX-1.1
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions
424B5
FATE
Fate Therapeutics Inc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
made and the conclusions reached in the following summary, and there can be no assurance that the IRS will agree with such statements and conclusions … value of our U.S. real property relative to the fair market value of our other business assets, there can be no assurance that we will not become